Journal Of Oncology Pharmacy Practice高引用文章

• Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

  引用次数：54

• Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

  引用次数：13

• Demonstrating the value of the oncology pharmacist within the healthcare team

  引用次数：12

• Pembrolizumab-induced myasthenia gravis: A fatal case report

  引用次数：11

• Adherence to oral chemotherapy: Challenges and opportunities

  引用次数：11

• Updates and novel treatments in urothelial carcinoma

  引用次数：9

• Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen

  引用次数：8

• Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events

  引用次数：8

• Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors

  引用次数：7

• Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma

  引用次数：7